|
US2788341A
(en)
*
|
1953-03-06 |
1957-04-09 |
Ciba Pharm Prod Inc |
Process for the manufacture of aminoacyl compounds
|
|
US3624097A
(en)
*
|
1969-07-22 |
1971-11-30 |
Warner Lambert Co |
N-pyridine 5-aminooxazoles
|
|
US4109496A
(en)
|
1977-12-20 |
1978-08-29 |
Norris Industries |
Trapped key mechanism
|
|
US4147343A
(en)
|
1978-02-25 |
1979-04-03 |
Hyde Phillip R |
Acrobatic amusement device
|
|
FR2568880B1
(fr)
|
1984-08-07 |
1986-12-12 |
Synthelabo |
Derives d'acylaminomethyl-3 imidazo(1,2-a)pyridines, leur preparation et leur application en therapeutique
|
|
US4868103A
(en)
|
1986-02-19 |
1989-09-19 |
Enzo Biochem, Inc. |
Analyte detection by means of energy transfer
|
|
US5080891A
(en)
|
1987-08-03 |
1992-01-14 |
Ddi Pharmaceuticals, Inc. |
Conjugates of superoxide dismutase coupled to high molecular weight polyalkylene glycols
|
|
EP0354785B1
(en)
|
1988-08-10 |
1993-03-31 |
Tokyo Sintered Metals Corp. |
Cycle type athletic equipment
|
|
US5223409A
(en)
|
1988-09-02 |
1993-06-29 |
Protein Engineering Corp. |
Directed evolution of novel binding proteins
|
|
US6905680B2
(en)
|
1988-11-23 |
2005-06-14 |
Genetics Institute, Inc. |
Methods of treating HIV infected subjects
|
|
US5858358A
(en)
|
1992-04-07 |
1999-01-12 |
The United States Of America As Represented By The Secretary Of The Navy |
Methods for selectively stimulating proliferation of T cells
|
|
US6534055B1
(en)
|
1988-11-23 |
2003-03-18 |
Genetics Institute, Inc. |
Methods for selectively stimulating proliferation of T cells
|
|
US6352694B1
(en)
|
1994-06-03 |
2002-03-05 |
Genetics Institute, Inc. |
Methods for inducing a population of T cells to proliferate using agents which recognize TCR/CD3 and ligands which stimulate an accessory molecule on the surface of the T cells
|
|
US5016870A
(en)
|
1990-02-09 |
1991-05-21 |
Bulloch Russell G |
Exercise device
|
|
TW204343B
(enExample)
*
|
1991-05-31 |
1993-04-21 |
Sumitomo Pharmaceutics Co Ltd |
|
|
CA2087413A1
(en)
|
1992-01-17 |
1993-07-18 |
Joseph R. Lakowicz |
Fluorescent energy transfer immunoassay
|
|
CA2148252C
(en)
|
1992-10-30 |
2007-06-12 |
Roger Brent |
Interaction trap system for isolating novel proteins
|
|
US5569128A
(en)
|
1994-02-03 |
1996-10-29 |
Icon Health & Fitness, Inc. |
Leg and upper body exerciser
|
|
US5656465A
(en)
|
1994-05-04 |
1997-08-12 |
Therion Biologics Corporation |
Methods of in vivo gene delivery
|
|
US7175843B2
(en)
|
1994-06-03 |
2007-02-13 |
Genetics Institute, Llc |
Methods for selectively stimulating proliferation of T cells
|
|
US7067318B2
(en)
|
1995-06-07 |
2006-06-27 |
The Regents Of The University Of Michigan |
Methods for transfecting T cells
|
|
US6692964B1
(en)
|
1995-05-04 |
2004-02-17 |
The United States Of America As Represented By The Secretary Of The Navy |
Methods for transfecting T cells
|
|
US5677158A
(en)
|
1995-06-07 |
1997-10-14 |
Research Foundation Of State University Of New York |
In vitro packaging of adeno-associated virus DNA
|
|
US5801030A
(en)
|
1995-09-01 |
1998-09-01 |
Genvec, Inc. |
Methods and vectors for site-specific recombination
|
|
US6180612B1
(en)
|
1997-10-31 |
2001-01-30 |
The University Of Virginia Patent Foundation |
Methods and compositions for targeting DNA metabolic processes using aminoglycoside derivatives
|
|
US6683058B1
(en)
|
1998-04-15 |
2004-01-27 |
Regents Of The University Of California |
Methods for therapy of neurodegenerative disease of the brain
|
|
WO1999061066A2
(en)
|
1998-05-27 |
1999-12-02 |
Avigen, Inc. |
Convection-enhanced delivery of aav vectors
|
|
JP2000095767A
(ja)
|
1998-09-28 |
2000-04-04 |
Takeda Chem Ind Ltd |
性腺刺激ホルモン放出ホルモン拮抗剤
|
|
AU6229699A
(en)
*
|
1998-10-26 |
2000-05-15 |
Sumitomo Pharmaceuticals Company, Limited |
Beta-amyloid formation inhibitors
|
|
JP2002541151A
(ja)
|
1999-04-02 |
2002-12-03 |
ニューロゲン コーポレイション |
アリールおよびヘテロアリール縮合アミノアルキル−イミダゾール誘導体：ＧＡＢＡａ受容体の選択的修飾物質
|
|
EP1165517A1
(en)
|
1999-04-02 |
2002-01-02 |
Neurogen Corporation |
N-benzimidazolylmethyl- and n-indolylmethyl-benzamides and their use as crf modulators
|
|
WO2001059094A2
(en)
|
2000-02-11 |
2001-08-16 |
The Salk Institute For Biological Studies |
Method of regulating transcription in a cell by altering remodeling of cromatin
|
|
US6797514B2
(en)
|
2000-02-24 |
2004-09-28 |
Xcyte Therapies, Inc. |
Simultaneous stimulation and concentration of cells
|
|
US7572631B2
(en)
|
2000-02-24 |
2009-08-11 |
Invitrogen Corporation |
Activation and expansion of T cells
|
|
BR0108545A
(pt)
|
2000-02-24 |
2004-06-29 |
Xcyte Therapies Inc |
Estimulação e concentração simultâneas das células
|
|
US6867041B2
(en)
|
2000-02-24 |
2005-03-15 |
Xcyte Therapies, Inc. |
Simultaneous stimulation and concentration of cells
|
|
US6547702B1
(en)
|
2000-03-29 |
2003-04-15 |
Innovative Applications, Inc. |
Exercise device
|
|
CA2410015A1
(en)
|
2000-05-26 |
2001-12-06 |
Thomas W. Dubensky, Jr. |
Methods of transducing neural cells using lentivirus vectors
|
|
US20030027335A1
(en)
|
2000-09-07 |
2003-02-06 |
Ruley H. Earl |
Genome engineering by cell-permeable DNA site-specific recombinases
|
|
US6551786B2
(en)
|
2001-01-04 |
2003-04-22 |
Myriad Genetics, Inc. |
Screen assay for selecting protein-protein interaction modulators
|
|
JP2003033179A
(ja)
|
2001-07-05 |
2003-02-04 |
Asahi Kasei Corp |
可逆的遺伝子導入ベクター
|
|
JP2003077651A
(ja)
|
2001-08-30 |
2003-03-14 |
Sharp Corp |
有機エレクトロルミネッセンス素子の製造方法
|
|
ES2367422T3
(es)
|
2001-10-09 |
2011-11-03 |
Amgen Inc. |
Derivados de imidazol como agentes antiinflamatorios.
|
|
US20050079512A1
(en)
|
2003-02-26 |
2005-04-14 |
Emerson Beverly M. |
Methods of modulating gene expression
|
|
US20040216178A1
(en)
|
2003-03-03 |
2004-10-28 |
Jones Stephen N |
Regulation of mdm2 function
|
|
WO2005007877A2
(en)
|
2003-07-18 |
2005-01-27 |
University Of Massachusetts |
Regulatable promoters for synthesis of small hairpin rna
|
|
ES2342397T3
(es)
|
2003-10-20 |
2010-07-06 |
Nsgene A/S |
Vector virico para su uso en terapia genica in vivo de la enfermedad de parkinson.
|
|
US20060058255A1
(en)
|
2004-03-01 |
2006-03-16 |
Jianzhu Chen |
RNAi-based therapeutics for allergic rhinitis and asthma
|
|
WO2005112620A2
(en)
|
2004-05-18 |
2005-12-01 |
Massachusetts Institute Of Technology |
A cre-lox based method for conditional rna interference
|
|
WO2006005941A1
(en)
|
2004-07-12 |
2006-01-19 |
Istituto Di Ricerche Di Biologia Molecolare P Angeletti S.P.A. |
Amide derivatives as inhibitors of histone deacetylase
|
|
CN101065377B
(zh)
|
2004-11-11 |
2011-07-27 |
菲尔若国际公司 |
咪唑并[1,2-a]吡啶化合物、组合物、与其有关的应用和方法
|
|
WO2006070806A1
(ja)
|
2004-12-28 |
2006-07-06 |
Taiho Pharmaceutical Co., Ltd. |
新規ベンゾイミダゾール化合物及び該化合物を含有する医薬組成物
|
|
WO2006119435A2
(en)
|
2005-05-04 |
2006-11-09 |
Invitrogen Corporation |
Identification of cancer biomarkers and phosphorylated proteins
|
|
AU2007288124B2
(en)
|
2006-08-24 |
2013-04-04 |
Australian Nuclear Science & Technology Organisation |
Fluorinated ligands for targeting peripheral benzodiazepine receptors
|
|
US8324367B2
(en)
|
2006-11-03 |
2012-12-04 |
Medtronic, Inc. |
Compositions and methods for making therapies delivered by viral vectors reversible for safety and allele-specificity
|
|
EP2148678A4
(en)
*
|
2007-05-23 |
2010-08-04 |
Siga Technologies Inc |
ANTIVIRAL DRUGS FOR THE TREATMENT AND PREVENTION OF DENGUE INFECTION
|
|
US20090209536A1
(en)
|
2007-06-17 |
2009-08-20 |
Kalypsys, Inc. |
Aminoquinazoline cannabinoid receptor modulators for treatment of disease
|
|
US7927258B2
(en)
|
2007-08-17 |
2011-04-19 |
Real Ryder, LLC |
Bicycling exercise apparatus
|
|
US8642660B2
(en)
|
2007-12-21 |
2014-02-04 |
The University Of Rochester |
Method for altering the lifespan of eukaryotic organisms
|
|
CA2618163A1
(en)
|
2008-02-07 |
2009-08-07 |
K. W. Michael Siu |
Head and neck cancer biomarkers
|
|
WO2009111277A1
(en)
|
2008-02-29 |
2009-09-11 |
Array Biopharma Inc. |
Imdizo [4. 5-b] pyridine derivatives used as raf inhibitors
|
|
EP2349484A2
(en)
*
|
2008-07-15 |
2011-08-03 |
Novartis AG |
Heteroaryl derivatives as dgat1 inhibitors
|
|
WO2010090654A1
(en)
|
2009-02-05 |
2010-08-12 |
Tdt, Ltd. |
Methods of reducing the proliferation and viability of microbial agents
|
|
ES2557465T3
(es)
*
|
2010-03-17 |
2016-01-26 |
Taivex Therapeutics Inc. |
Moduladores de la actividad de HEC 1 y procedimientos para ello
|
|
EP2561351B1
(en)
|
2010-04-22 |
2015-12-09 |
British Columbia Cancer Agency Branch |
Novel biomarkers and targets for ovarian carcinoma
|
|
WO2012015937A2
(en)
|
2010-07-29 |
2012-02-02 |
The Regents Of The University Of Michigan |
Parp1 targeted therapy
|
|
US9072052B2
(en)
|
2010-08-09 |
2015-06-30 |
Blackberry Limited |
Communication system providing context-based mobile wireless communications device power consumption management and related methods
|
|
US8647240B2
(en)
|
2010-10-08 |
2014-02-11 |
Innovative Applications, Inc. |
Exercise device
|
|
JP2014500303A
(ja)
|
2010-12-22 |
2014-01-09 |
パーデュー、ファーマ、リミテッド、パートナーシップ |
ナトリウムチャネル遮断剤としての置換ピリジン
|
|
AU2012240246A1
(en)
|
2011-04-04 |
2013-05-09 |
Netherlands Cancer Institute |
Methods and compositions for predicting resistance to anticancer treatment with protein kinase inhibitors
|
|
CN114262690A
(zh)
|
2011-04-15 |
2022-04-01 |
吉恩勒克斯公司 |
减毒的痘苗病毒的克隆毒株及其使用方法
|
|
EP2811999B1
(en)
|
2012-02-01 |
2021-10-27 |
The Trustees of Columbia University in the City of New York |
Novel cysteine protease inhibitors and uses thereof
|
|
WO2013116682A1
(en)
|
2012-02-02 |
2013-08-08 |
Ensemble Therapeutics Corporation |
Macrocyclic compounds for modulating il-17
|
|
US9227106B2
(en)
|
2012-05-21 |
2016-01-05 |
Todd Richards |
Weight lifting machine
|
|
LT3401400T
(lt)
|
2012-05-25 |
2019-06-10 |
The Regents Of The University Of California |
Būdai ir kompozicijos, skirtos rnr molekulės nukreipiamai tikslinės dnr modifikacijai ir rnr molekulės nukreipiamam transkripcijos moduliavimui
|
|
CN114634950A
(zh)
|
2012-12-12 |
2022-06-17 |
布罗德研究所有限公司 |
用于序列操纵的crispr-cas组分系统、方法以及组合物
|
|
US8697359B1
(en)
|
2012-12-12 |
2014-04-15 |
The Broad Institute, Inc. |
CRISPR-Cas systems and methods for altering expression of gene products
|
|
ES2576126T3
(es)
|
2012-12-12 |
2016-07-05 |
The Broad Institute, Inc. |
Modificación por tecnología genética y optimización de sistemas, métodos y composiciones enzimáticas mejorados para la manipulación de secuencias
|
|
US9410943B2
(en)
|
2013-03-14 |
2016-08-09 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods, compositions and screens for therapeutics for the treatment of synovial sarcoma
|
|
US10131637B2
(en)
|
2013-03-15 |
2018-11-20 |
Shifa Biomedical Corporation |
Anti-PCSK9 compounds and methods for the treatment and/or prevention of cardiovascular diseases
|
|
ES2900301T3
(es)
|
2013-03-15 |
2022-03-16 |
Novartis Ag |
Biomarcadores asociados con la inhibición de BRM
|
|
US10976320B2
(en)
|
2013-05-21 |
2021-04-13 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods for identifying and treating cancer patients
|
|
ES2950424T3
(es)
|
2013-07-03 |
2023-10-09 |
Takeda Pharmaceuticals Co |
Compuesto de amida
|
|
WO2015005473A1
(ja)
|
2013-07-12 |
2015-01-15 |
独立行政法人国立がん研究センター |
がんの治療への応答性を予測する方法
|
|
WO2015007517A1
(en)
|
2013-07-15 |
2015-01-22 |
Boehringer Ingelheim International Gmbh |
Novel tetra- and pentasubstituted benzimidazolium compounds
|
|
JPWO2015046193A1
(ja)
|
2013-09-25 |
2017-03-09 |
塩野義製薬株式会社 |
Ｔｒｐｖ４阻害活性を有する芳香族複素環式アミン誘導体
|
|
CN106061480B
(zh)
|
2013-12-30 |
2020-02-28 |
莱福斯希医药公司 |
治疗性抑制性化合物
|
|
EP3102193B1
(en)
|
2014-02-06 |
2023-01-11 |
Rutgers, The State University of New Jersey |
Antibacterial agents: n(alpha)-aroyl-n-aryl-phenylalaninamides
|
|
GB201402771D0
(en)
|
2014-02-17 |
2014-04-02 |
Isis Innovation |
Biomarker & therapeutic target for sarcoma
|
|
PL3177640T3
(pl)
|
2014-08-08 |
2020-11-02 |
The Board Of Trustees Of The Leland Stanford Junior University |
Charakteryzujące się wysokim powinowactwem środki terapeutyczne naśladujące PD-11 i sposoby ich wykorzystania
|
|
US9708348B2
(en)
|
2014-10-03 |
2017-07-18 |
Infinity Pharmaceuticals, Inc. |
Trisubstituted bicyclic heterocyclic compounds with kinase activities and uses thereof
|
|
US9636323B2
(en)
|
2014-10-27 |
2017-05-02 |
Baylor College Of Medicine |
Method of treating cancer that overexpresses TopBP1
|
|
CN104530013B
(zh)
|
2014-12-04 |
2016-06-29 |
中国农业大学 |
基于吲哚环的吡唑酰胺类化合物作为农用杀菌剂的用途
|
|
US9546296B2
(en)
|
2014-12-15 |
2017-01-17 |
Ppg Industries Ohio, Inc. |
Coating compositions, coatings and methods for sound and vibration damping and water resistance
|
|
US9932340B2
(en)
|
2014-12-18 |
2018-04-03 |
Abbvie Inc. |
Substituted indoles
|
|
JP6815318B2
(ja)
|
2014-12-23 |
2021-01-20 |
ダナ−ファーバー キャンサー インスティテュート，インコーポレイテッド |
二官能性分子によって標的化タンパク質分解を誘導する方法
|
|
US9694084B2
(en)
|
2014-12-23 |
2017-07-04 |
Dana-Farber Cancer Institute, Inc. |
Methods to induce targeted protein degradation through bifunctional molecules
|
|
MA41598A
(fr)
*
|
2015-02-25 |
2018-01-02 |
Constellation Pharmaceuticals Inc |
Composés thérapeutiques de pyridazine et leurs utilisations
|
|
US10363256B2
(en)
*
|
2015-03-27 |
2019-07-30 |
University Of Washington |
Methods for treatment of retinal disease by photoreceptor gene expression modulation
|
|
WO2016164482A1
(en)
|
2015-04-06 |
2016-10-13 |
The University Of North Carolina At Chapel Hill |
Methods and compositions for treatment of heart failure
|
|
EP3108883A1
(en)
*
|
2015-06-22 |
2016-12-28 |
Fundació Institut de Recerca Biomèdica de Bellvitge |
Therapeutic uses of non-peptide inhibitors of the calcineurin - nfat signalling pathway
|
|
WO2017007612A1
(en)
|
2015-07-07 |
2017-01-12 |
Dana-Farber Cancer Institute, Inc. |
Methods to induce targeted protein degradation through bifunctional molecules
|
|
AU2016301196B2
(en)
|
2015-08-06 |
2022-09-08 |
Dana-Farber Cancer Institute, Inc. |
Tunable endogenous protein degradation
|
|
US9630049B2
(en)
|
2015-09-21 |
2017-04-25 |
Joseph D Hartman |
Reciprocating rehabilitation device
|
|
US20170100396A1
(en)
|
2015-10-07 |
2017-04-13 |
F. Hoffmann-La Roche Ag |
Pyrrolopyrazine derivatives for use in the treatment, amelioration or prevention of influenza
|
|
UA123401C2
(uk)
|
2015-10-15 |
2021-03-31 |
Аджиос Фармасьютікалз, Інк. |
Комбінована терапія для лікування злоякісних пухлин
|
|
US12282014B2
(en)
|
2015-11-19 |
2025-04-22 |
Dana-Farber Cancer Institute, Inc. |
Methods of identifying compounds that interfere with ERG-driven misguidance of BAF complexes in TMPRSS2-ERG driven prostate cancers
|
|
WO2017118734A1
(en)
|
2016-01-08 |
2017-07-13 |
The Institute Of Cancer Research: Royal Cancer Hospital |
Inhibitors of ataxia-telangiectasia mutated and rad3-related protein kinase (atr) for use in methods of treating cancer
|
|
WO2017146795A1
(en)
|
2016-02-26 |
2017-08-31 |
Agios Pharmaceuticals, Inc. |
Idh1 inhibitors for the treatment of haematological malignancies and solid tumours
|
|
GB201604638D0
(en)
|
2016-03-18 |
2016-05-04 |
Mission Therapeutics Ltd |
Novel compounds
|
|
CN109562107A
(zh)
|
2016-05-10 |
2019-04-02 |
C4医药公司 |
用于靶蛋白降解的杂环降解决定子体
|
|
CN109641874A
(zh)
|
2016-05-10 |
2019-04-16 |
C4医药公司 |
用于靶蛋白降解的c3-碳连接的戊二酰亚胺降解决定子体
|
|
EP4483875A3
(en)
|
2016-05-10 |
2025-04-02 |
C4 Therapeutics, Inc. |
Spirocyclic degronimers for target protein degradation
|
|
WO2018064589A1
(en)
|
2016-09-29 |
2018-04-05 |
Dana-Farber Cancer Institute, Inc. |
Targeted protein degradation using a mutant e3 ubiquitin ligase
|
|
US10207998B2
(en)
|
2016-09-29 |
2019-02-19 |
Duke University |
Substituted benzimidazole and substituted benzothiazole inhibitors of transforming growth factor-β kinase and methods of use thereof
|
|
US12023385B2
(en)
|
2017-02-08 |
2024-07-02 |
Dana-Farber Cancer Institute, Inc. |
Tunable endogenous protein degradation with heterobifunctional compounds
|
|
JP2020508995A
(ja)
|
2017-02-28 |
2020-03-26 |
エピザイム，インコーポレイティド |
癌の処置のためのｓｍａｒｃａ２の阻害
|
|
EP3601326A4
(en)
|
2017-03-20 |
2020-12-16 |
The Broad Institute, Inc. |
COMPOUNDS AND METHODS OF REGULATING INSULIN SECRETION
|
|
CN110997662B
(zh)
|
2017-08-21 |
2023-10-31 |
默克专利股份公司 |
作为腺苷受体拮抗剂的苯并咪唑衍生物
|
|
WO2019040098A1
(en)
|
2017-08-21 |
2019-02-28 |
Dana-Farber Cancer Institute, Inc. |
METHODS OF MODULATING THE INTERACTION BETWEEN BAF COMPLEXES AND EWS-FLI1
|
|
EP3740478B1
(en)
|
2018-01-15 |
2023-11-01 |
UCB Biopharma SRL |
Fused imidazole derivatives as il-17 modulators
|
|
EP3740482A1
(en)
|
2018-01-17 |
2020-11-25 |
Migal Galilee Research Institute Ltd. |
New methionine metabolic pathway inhibitors
|
|
EP3746135A4
(en)
|
2018-01-30 |
2022-03-09 |
Foghorn Therapeutics Inc. |
METHODS AND COMPOUNDS FOR TREATMENT OF DISEASE
|
|
US11497752B2
(en)
|
2018-01-30 |
2022-11-15 |
Foghorn Therapeutics Inc. |
Compounds and uses thereof
|
|
US11447502B2
(en)
*
|
2018-05-25 |
2022-09-20 |
Rutgers, The State University Of New Jersey |
Antibacterial agents: dual-targeted RNA polymerase inhibitors
|
|
WO2019246423A1
(en)
|
2018-06-21 |
2019-12-26 |
Foghorn Therapeutics Inc. |
Methods of treating disorders
|
|
WO2019246430A1
(en)
|
2018-06-21 |
2019-12-26 |
Foghorn Therapeutics Inc. |
Methods of treating disorders
|
|
EP3837256B1
(en)
|
2018-08-17 |
2023-03-08 |
Novartis AG |
Urea compounds and compositions as smarca2/brm-atpase inhibitors
|
|
US20210171958A1
(en)
|
2018-08-23 |
2021-06-10 |
Foghorn Therapeutics Inc. |
Methods of treating cancer
|
|
WO2020081588A1
(en)
|
2018-10-17 |
2020-04-23 |
Dana-Farber Cancer Institute, Inc. |
Swi/snf family chromatin remodeling complexes and uses thereof
|
|
WO2020081556A2
(en)
|
2018-10-17 |
2020-04-23 |
Dana-Farber Cancer Institute, Inc. |
Non-canonical swi/snf complex and uses thereof
|
|
WO2020106915A1
(en)
|
2018-11-21 |
2020-05-28 |
Foghorn Therapeutics Inc. |
Methods of treating cancers
|
|
CN113164448A
(zh)
|
2018-12-19 |
2021-07-23 |
利奥制药有限公司 |
作为il-17的小分子调节剂的氨基酸苯胺类化合物
|
|
WO2020160196A1
(en)
|
2019-01-29 |
2020-08-06 |
Foghorn Therapeutics Inc. |
Compounds and uses thereof
|
|
ES3032327T3
(en)
|
2019-01-29 |
2025-07-17 |
Foghorn Therapeutics Inc |
Compounds and uses thereof
|
|
WO2020160100A1
(en)
|
2019-01-29 |
2020-08-06 |
Foghorn Therapeutics Inc. |
Compounds and uses thereof
|
|
JP2022525149A
(ja)
|
2019-03-20 |
2022-05-11 |
スミトモ ダイニッポン ファーマ オンコロジー， インコーポレイテッド |
ベネトクラクスが失敗した急性骨髄性白血病（ａｍｌ）の処置
|
|
BR112022004573A2
(pt)
|
2019-09-12 |
2022-06-07 |
Aurigene Discovery Tech Ltd |
Método para identificar respondedores para degradadores de smarca2/4
|
|
WO2021081032A1
(en)
|
2019-10-25 |
2021-04-29 |
Dana-Farber Cancer Institute, Inc. |
Compositions comprising modified smarcb1 and uses thereof
|
|
EA202192101A1
(ru)
|
2019-11-21 |
2021-12-09 |
Фогхорн Терапьютикс Инк. |
Соединения и их применение
|
|
BR112022015004A2
(pt)
|
2020-01-29 |
2022-09-20 |
Foghorn Therapeutics Inc |
Composto, composição farmacêutica, métodos para diminuir a atividade de um complexo baf, induzir apoptose, reduzir o crescimento tumoral, suprimir a progressão e a colonização metastática do câncer e reduzir o nível e/ou a atividade de brg1 e/ou brm em um câncer e métodos de tratamento e de inibição de brm e brg1
|
|
EP4096668A4
(en)
|
2020-01-29 |
2024-02-28 |
Foghorn Therapeutics Inc. |
COMPOUNDS AND USES THEREOF
|
|
KR20220133259A
(ko)
|
2020-01-29 |
2022-10-04 |
포그혼 쎄라퓨틱스 인크. |
화합물 및 이의 용도
|
|
MX2022009367A
(es)
|
2020-01-29 |
2022-10-27 |
Foghorn Therapeutics Inc |
Compuestos y usos de estos.
|
|
WO2021155320A1
(en)
|
2020-01-29 |
2021-08-05 |
Foghorn Therapeutics Inc. |
Compounds and uses thereof
|
|
CN115335373B
(zh)
|
2020-01-29 |
2025-05-20 |
福宏治疗公司 |
化合物及其用途
|
|
WO2021183218A1
(en)
|
2020-03-13 |
2021-09-16 |
Dana-Farber Cancer Institute, Inc. |
Compositions and methods for modulating the interaction between ss18-ssx fusion oncoprotein and nucleosomes
|
|
EP4153176A4
(en)
|
2020-05-20 |
2024-05-29 |
Foghorn Therapeutics Inc. |
METHODS OF TREATING CANCER
|
|
US12383555B2
(en)
|
2020-05-20 |
2025-08-12 |
Foghorn Therapeutics Inc. |
Methods of treating cancers
|
|
JP2024509268A
(ja)
|
2021-03-09 |
2024-02-29 |
フォグホーン セラピューティクス インコーポレイテッド |
結晶形、それらを含有する組成物、及びそれらの使用方法
|
|
WO2022192621A1
(en)
|
2021-03-12 |
2022-09-15 |
Celgene Corporation |
Methods for using a hypomethylating agent to treat diseases and disorders based on gene mutation profiles
|
|
EP4308124A4
(en)
|
2021-03-19 |
2025-01-15 |
Foghorn Therapeutics Inc. |
THERAPEUTIC SCHEMES FOR AN INHIBITOR OF THE ENZYMATIC ACTIVITY OF BRG1 AND BRM
|
|
EP4376886A4
(en)
|
2021-07-29 |
2025-05-14 |
Foghorn Therapeutics Inc. |
Methods of treating cancer
|
|
US20250339441A1
(en)
|
2022-04-08 |
2025-11-06 |
Foghorn Therapeutics Inc. |
Methods of treating cancer
|
|
JP2025511859A
(ja)
|
2022-04-08 |
2025-04-16 |
フォグホーン セラピューティクス インコーポレイテッド |
血液細胞分化に関連する臨床的に有意な徴候及び症状を有する対象を治療する方法
|
|
US20250325553A1
(en)
|
2022-04-08 |
2025-10-23 |
Foghorn Therapeutics Inc. |
Methods of treating cancer
|
|
WO2024024428A1
(ja)
|
2022-07-29 |
2024-02-01 |
株式会社Soken |
電力変換装置
|
|
CN218451564U
(zh)
|
2022-08-09 |
2023-02-07 |
宁波立奇电器有限公司 |
一种双锅双风道式空气炸锅
|
|
WO2024086577A1
(en)
|
2022-10-17 |
2024-04-25 |
Foghorn Therapeutics Inc. |
Methods of reducing or preventing metastases
|
|
WO2024216151A1
(en)
|
2023-04-13 |
2024-10-17 |
Foghorn Therapeutics Inc. |
Combination therapy for treating hematological cancers
|
|
WO2024216136A1
(en)
|
2023-04-13 |
2024-10-17 |
Foghorn Therapeutics Inc. |
Combination therapy for the treatment of hematological cancers
|